Milestone Pharmaceuticals Inc. Increase (Decrease) in Other Receivables
Milestone Pharmaceuticals Inc. (MIST) reported Increase (Decrease) in Other Receivables of -$920.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2026-08-12
- Milestone Pharmaceuticals Inc. increase (decrease) in other receivables for the quarter ending 2026-06-30 was -$699.00K.
- Milestone Pharmaceuticals Inc. increase (decrease) in other receivables for the quarter ending 2026-03-31 was -$221.00K.
- Milestone Pharmaceuticals Inc. increase (decrease) in other receivables for the quarter ending 2025-12-31 was $946.00K, a 239.07% increase year-over-year.
- Milestone Pharmaceuticals Inc. increase (decrease) in other receivables for the quarter ending 2025-09-30 was -$224.00K.
- Milestone Pharmaceuticals Inc. increase (decrease) in other receivables for fiscal 2025 was $156.00K.
- Milestone Pharmaceuticals Inc. increase (decrease) in other receivables for fiscal 2024 was -$1.72M, a 173.86% decline from fiscal 2023.
- Milestone Pharmaceuticals Inc. increase (decrease) in other receivables for fiscal 2023 was $2.33M, a 208.08% increase from fiscal 2022.
- Milestone Pharmaceuticals Inc. increase (decrease) in other receivables for fiscal 2022 was $755.00K.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 3 month as first filed | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$699.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$920.00K 10-Q · filed 2026-08-12 | $26.00K derived: sum of 3 quarters · filed 2026-08-12 | -$198.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | -$221.00K 10-Q · filed 2026-05-13 | $725.00K derived: sum of 2 quarters · filed 2026-05-13 | $501.00K derived: sum of 3 quarters · filed 2026-05-13 | $258.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | $946.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $722.00K derived: sum of 2 quarters · filed 2026-03-20 | $479.00K derived: sum of 3 quarters · filed 2026-08-12 | $156.00K 10-K · filed 2026-03-20 | |
| 2025-09-30 | -$224.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$467.00K derived: sum of 2 quarters · filed 2026-08-12 | -$790.00K 10-Q · filed 2025-11-12 | -$511.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | -$243.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$566.00K 10-Q · filed 2026-08-12 | -$287.00K derived: sum of 3 quarters · filed 2026-08-12 | -$693.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | -$323.00K 10-Q · filed 2026-05-13 | -$44.00K derived: sum of 2 quarters · filed 2026-05-13 | -$450.00K derived: sum of 3 quarters · filed 2026-05-13 | -$246.00K derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $279.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | -$127.00K derived: sum of 2 quarters · filed 2026-03-20 | $77.00K derived: sum of 3 quarters · filed 2026-03-20 | -$1.72M 10-K · filed 2026-03-20 | |
| 2024-09-30 | -$406.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$202.00K derived: sum of 2 quarters · filed 2025-11-12 | -$2.00M 10-Q · filed 2025-11-12 | -$310.00K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $204.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$1.59M 10-Q · filed 2025-08-12 | $96.00K derived: sum of 3 quarters · filed 2025-08-12 | $525.00K derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | -$1.79M 10-Q · filed 2025-05-14 | -$108.00K derived: sum of 2 quarters · filed 2025-05-14 | $321.00K derived: sum of 3 quarters · filed 2025-05-14 | $719.00K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $2.12M derived: sum of 2 quarters · filed 2025-03-13 | $2.51M derived: sum of 3 quarters · filed 2025-03-13 | $2.33M 10-K · filed 2025-03-13 | |
| 2023-09-30 | $429.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $827.00K derived: sum of 2 quarters · filed 2024-11-12 | $639.00K 10-Q · filed 2024-11-12 | $1.09M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $398.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $210.00K 10-Q · filed 2024-08-08 | $657.00K derived: sum of 3 quarters · filed 2024-08-08 | $831.00K derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | -$188.00K 10-Q · filed 2024-05-13 | $259.00K derived: sum of 2 quarters · filed 2024-05-13 | $433.00K derived: sum of 3 quarters · filed 2024-05-13 | $449.00K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | $447.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $621.00K derived: sum of 2 quarters · filed 2024-03-21 | $637.00K derived: sum of 3 quarters · filed 2024-03-21 | $755.00K 10-K · filed 2024-03-21 | |
| 2022-09-30 | $174.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $190.00K derived: sum of 2 quarters · filed 2023-11-13 | $308.00K 10-Q · filed 2023-11-13 | $346.00K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $134.00K 10-Q · filed 2023-08-10 | $172.00K derived: sum of 3 quarters · filed 2023-08-10 | $19.00K derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $118.00K 10-Q · filed 2023-05-11 | $156.00K derived: sum of 2 quarters · filed 2023-05-11 | $3.00K derived: sum of 3 quarters · filed 2023-05-11 | -$32.00K derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$115.00K derived: sum of 2 quarters · filed 2023-03-29 | -$150.00K derived: sum of 3 quarters · filed 2023-03-29 | -$96.00K 10-K · filed 2023-03-29 | |
| 2021-09-30 | -$153.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$188.00K derived: sum of 2 quarters · filed 2022-11-10 | -$134.00K 10-Q · filed 2022-11-10 | -$94.00K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | -$35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $19.00K 10-Q · filed 2022-08-10 | $59.00K derived: sum of 3 quarters · filed 2022-08-10 | -$76.00K derived: sum of 4 quarters · filed 2022-08-10 | |
| 2021-03-31 | $54.00K 10-Q · filed 2022-05-12 | $94.00K derived: sum of 2 quarters · filed 2022-05-12 | -$41.00K derived: sum of 3 quarters · filed 2022-05-12 | $18.00K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$95.00K derived: sum of 2 quarters · filed 2022-03-24 | -$36.00K derived: sum of 3 quarters · filed 2022-03-24 | -$35.00K 10-K · filed 2022-03-24 | |
| 2020-09-30 | -$135.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$76.00K derived: sum of 2 quarters · filed 2021-11-12 | -$75.00K 10-Q · filed 2021-11-12 | -$304.00K derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | $59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $60.00K 10-Q · filed 2021-08-11 | -$169.00K derived: sum of 3 quarters · filed 2021-08-11 | -$10.00K derived: sum of 4 quarters · filed 2021-08-11 | |
| 2020-03-31 | $1.00K 10-Q · filed 2021-05-17 | -$228.00K derived: sum of 2 quarters · filed 2021-05-17 | -$69.00K derived: sum of 3 quarters · filed 2021-05-17 | $10.00K derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | -$229.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | -$70.00K derived: sum of 2 quarters · filed 2021-03-29 | $9.00K derived: sum of 3 quarters · filed 2021-03-29 | -$119.00K 10-K · filed 2021-03-29 | |
| 2019-09-30 | $159.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $238.00K derived: sum of 2 quarters · filed 2020-11-13 | $110.00K 10-Q · filed 2020-11-13 | $367.00K derived: sum of 4 quarters · filed 2020-11-13 | |
| 2019-06-30 | $79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$49.00K 10-Q · filed 2020-08-12 | $208.00K derived: sum of 3 quarters · filed 2020-10-23 | $153.00K derived: sum of 4 quarters · filed 2020-10-23 | |
| 2019-03-31 | -$128.00K 10-Q · filed 2020-05-14 | -$122.00K 10-Q · filed 2019-06-19 | $129.00K derived: sum of 2 quarters · filed 2020-10-23 | $74.00K derived: sum of 3 quarters · filed 2020-10-23 | $118.00K derived: sum of 4 quarters · filed 2020-10-23 |
| 2018-12-31 | $257.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-10-23 | $202.00K derived: sum of 2 quarters · filed 2020-10-23 | $246.00K derived: sum of 3 quarters · filed 2020-10-23 | $271.00K 10-K/A · filed 2020-10-23 | |
| 2018-09-30 | -$55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$11.00K derived: sum of 2 quarters · filed 2019-11-13 | $14.00K 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $69.00K 10-Q · filed 2019-08-13 | |||
| 2018-03-31 | $25.00K 10-Q · filed 2019-06-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B |